Clinical Trials Logo

Spondyloarthritis, Axial clinical trials

View clinical trials related to Spondyloarthritis, Axial.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00741793 Completed - Clinical trials for Arthritis, Rheumatoid

Biologic Treatment Registry Across Canada

BioTRAC
Start date: February 12, 2002
Phase:
Study type: Observational

This registry is a multi-center, prospective, longitudinal, observational program that will gather and analyse data on participants treated with infliximab, golimumab, golimumab Intravenous (I.V) or ustekinumab. Treatment will be prescribed by the physician according to actual clinical practice or standard of care for Rheumatoid Arthritis (RA), Axial Spondyloarthritis (AxSpA) , Psoriatic Arthritis (PsA); there will be no randomized assignments to treatment. At baseline and approximately every 6 months thereafter, information will be collected to assess safety, clinical outcomes, quality of life, comorbidities, pharmacoeconomics and treatment regimens among cohorts of participants receiving infliximab, golimumab, golimumab I.V or ustekinumab for the treatment of RA, AxSpA and PsA.